Elevated ALT activities were used to assess nonalcoholic fatty liver disease (NAFLD) compared with biopsies, ultrasound scans, or magnetic resonance imaging (28). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.